News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
245,217 Results
Type
Article (13337)
Company Profile (20)
Press Release (231860)
Section
Business (73094)
Career Advice (520)
Deals (12083)
Drug Delivery (31)
Drug Development (46826)
Employer Resources (56)
FDA (6126)
Job Trends (5499)
News (135935)
Policy (11159)
Tag
Academia (1078)
Alliances (17261)
Alzheimer's disease (613)
Approvals (6128)
Artificial intelligence (46)
Bankruptcy (80)
Best Places to Work (4772)
Breast cancer (98)
Cancer (813)
Career advice (446)
CAR-T (48)
Cell therapy (135)
Clinical research (37809)
Collaboration (223)
Compensation (48)
COVID-19 (995)
Data (899)
Diabetes (81)
Diagnostics (1728)
Earnings (34861)
Employer resources (43)
Events (32710)
Executive appointments (127)
FDA (6467)
Funding (186)
Gene therapy (70)
GLP-1 (349)
Government (1603)
Healthcare (7203)
Infectious disease (1027)
Inflammatory bowel disease (80)
Interviews (82)
IPO (6821)
Job creations (934)
Job search strategy (390)
Layoffs (145)
Legal (1547)
Lung cancer (122)
Lymphoma (71)
Manufacturing (84)
Medical device (3946)
Medtech (3947)
Mergers & acquisitions (5379)
Metabolic disorders (231)
Neuroscience (801)
NextGen Class of 2024 (2070)
Non-profit (1389)
Northern California (837)
Obesity (134)
Opinion (51)
Parkinson's disease (55)
Patents (50)
People (17674)
Phase I (12522)
Phase II (17153)
Phase III (11822)
Pipeline (380)
Postmarket research (1078)
Preclinical (5218)
Radiopharmaceuticals (119)
Rare diseases (124)
Real estate (1485)
Regulatory (8657)
Research institute (978)
Resumes & cover letters (69)
Southern California (699)
Startups (1149)
United States (6720)
Vaccines (182)
Weight loss (97)
Date
Last 7 days (275)
Last 30 days (1106)
Last 365 days (16749)
2024 (16671)
2023 (19041)
2022 (24376)
2021 (25671)
2020 (23228)
2019 (17405)
2018 (13202)
2017 (13231)
2016 (11592)
2015 (13596)
2014 (9288)
2013 (6779)
2012 (7063)
2011 (7479)
2010 (6581)
Location
Africa (190)
Asia (16613)
Australia (3022)
California (1807)
Canada (754)
China (159)
Colorado (83)
Connecticut (79)
Delaware (53)
Europe (36452)
Florida (243)
Georgia (50)
Illinois (131)
Indiana (100)
Japan (54)
Kansas (47)
Maryland (253)
Massachusetts (1313)
Michigan (46)
Minnesota (116)
New Jersey (545)
New York (571)
North Carolina (325)
Northern California (837)
Ohio (50)
Pennsylvania (343)
South America (304)
Southern California (699)
Texas (246)
Washington State (192)
245,217 Results for "active motif".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Lone Star Bio
Motif Neurotech Raises $18.75 Million in Series A Financing to Advance Implantable Device for Treatment-Resistant Depression
Motif Neurotech announced today an oversubscribed Series A financing of $18.75 million led by Arboretum Ventures.
January 24, 2024
·
3 min read
Business
Motif Neurotech Strengthens Leadership Team with Appointment of Steven Goetz as Chief Technology Officer
Motif Neurotech , a clinical-stage company developing minimally invasive bioelectronics for mental health, announces the appointment of Steven Goetz as Chief Technology Officer.
July 24, 2023
·
4 min read
Lone Star Bio
Motif Neurotech Conducts First-in-human Brain Stimulation With Millimeter-sized Implantable Device for Treatment-resistant Depression
Motif Neurotech, a neurotechnology company developing minimally invasive bioelectronics for mental health, announced today new research published to the preprint server medrxiv that demonstrates a millimeter-sized brain stimulator in a human subject.
September 18, 2023
·
5 min read
Deals
Active Motif Incorporated Announces the Acquisition of Amaryllis Nucleics and their proprietary RNASeq workflow
Active Motif Incorporated, a company with the vision of bringing epigenetics more deeply into precision medicine, announced that it has purchased Amaryllis Nucleics, a Bay Area-based start-up company focused on proprietary RNA Sequencing methods.
January 27, 2022
·
1 min read
Alzheimer’s disease
New Wave of Alzheimer’s Therapies Actively Engage the Immune System
Active immune therapies hold promise for preventing or slowing disease onset, but some experts warn of potential safety risks.
August 5, 2024
·
5 min read
·
Gail Dutton
Biotech Bay
NovaBay Pharmaceuticals and Eyenovia Commence Co-Promotion Activities
NovaBay® Pharmaceuticals, Inc. and Eyenovia, Inc. have commenced activities under a previously announced co-promotion agreement.
July 1, 2024
·
8 min read
Deals
Biopharma Investment Activity Continued to Rise in Q2: J.P. Morgan
A report from J.P. Morgan shows an increase in biopharma activity so far this year and where some improvement can be made.
July 31, 2024
·
3 min read
·
Tyler Patchen
Press Releases
Psyence Biomed Highlights Recent Progress on Active Phase IIb Clinical Trial
December 17, 2024
·
6 min read
Pharm Country
A Novel Broad-Spectrum Antiviral with Activity Against Smallpox/Mpox
NanoViricides, Inc., a global leader in broad-spectrum antiviral nanomedicines, says that the ultra-broad antiviral activity spectrum of NV-387 includes activity against orthopoxvirus family, with both inhalation and skin abrasion modes of infection acquisition.
May 8, 2024
·
8 min read
Press Releases
Olema Oncology Presents Compelling New Preclinical Data Demonstrating Anti-Tumor Activity for OP-3136 with Enhanced Activity of Palazestrant Combinations at ENA 2024
October 24, 2024
·
8 min read
1 of 24,522
Next
